Panaxtriol

CAS No. 32791-84-7

Panaxtriol( —— )

Catalog No. M18426 CAS No. 32791-84-7

Panaxatriol can relieve myelosuppression induced by radiation injury.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
10MG 29 In Stock
25MG 46 In Stock
50MG 73 In Stock
100MG 105 In Stock
200MG Get Quote In Stock
500MG 254 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Panaxtriol
  • Note
    Research use only, not for human use.
  • Brief Description
    Panaxatriol can relieve myelosuppression induced by radiation injury.
  • Description
    Panaxatriol can relieve myelosuppression induced by radiation injury.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    Adrenergic Receptor
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    32791-84-7
  • Formula Weight
    476.39
  • Molecular Formula
    C30H52O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (52.44 mM)
  • SMILES
    C[C@@]1(CCCC(O1)(C)C)[C@H]2CC[C@@]3([C@@H]2[C@@H](C[C@H]4[C@]3(C[C@H]([C@@H]5[C@@]4(CC[C@@H](C5(C)C)O)C)O)C)O)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Cheng Y, Shen LH, Zhang JT. Acta Pharmacol Sin. 2005 Feb;26(2):143-9.
molnova catalog
related products
  • Clonidine

    Clonidine is a centrally active alpha-adrenergic agonist used predominantly as an antihypertensive agent usually in combination with other agents. Despite wide-scale use for many years clonidine has not been linked definitively to either serum aminotransferase elevations or clinically apparent liver injury.

  • Clenbuterol

    Clenbuterol is a substituted phenylaminoethanol that has β2 adrenomimetic properties at very low doses, and is used as a bronchodilator in asthma.

  • Diosgenin glucoside

    Diosgenin glucoside and other synthetic glycosides with similar activities may be of use in the management of hypercholesterolemia and atherosclerosis.